Clinical trial

Famotidine in Schizophrenia

NCT01946295

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-03-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2014-03-01Date precision: month

Registry last updated2015-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Sponsors & collaborators

Jesper Ekelundlead sponsor

Karolinska Institutetcollaborator

Region Stockholmcollaborator

City of Helsinkicollaborator

Stanley Medical Research Institutecollaborator

Ahokas foundation, Finlandcollaborator

Mapped research locations

HelsinkiFinland3 StockholmSweden2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01946295 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.